Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 192

Results For "ET"

10720 News Found

Corbevax to be administered to children between 12-14 years
News | March 14, 2022

Corbevax to be administered to children between 12-14 years

Govt announces vaccination programme for kids and those above 60 years of age


First-in-human trial in US for Gan & Lee type 2 diabetes drug
Biotech | March 11, 2022

First-in-human trial in US for Gan & Lee type 2 diabetes drug

The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers


Strides receives USFDA approval for Colchicine tablets
Drug Approval | March 11, 2022

Strides receives USFDA approval for Colchicine tablets

Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout


Metropolis Healthcare announces 2nd edition of Healthcare Heroes awards
Clinical Trials | March 10, 2022

Metropolis Healthcare announces 2nd edition of Healthcare Heroes awards

As a part of its CSR initiatives, the ‘Healthcare Heroes of India’ Awards by Metropolis aims to identify and recognize those individuals and institutions in healthcare sector with a strong sense of purpose and commitment towards patient care and who have prioritized it over all other growth parameters


Medical devices production under PLI scheme gets off the ground
News | March 10, 2022

Medical devices production under PLI scheme gets off the ground

A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore


Artificial retinal device mimics human optical illusions: WPI-MANA
Biotech | March 10, 2022

Artificial retinal device mimics human optical illusions: WPI-MANA

The team built a multiple ionic device system, each of which had a lithium cobalt oxide channel arranged on a common lithium phosphorus oxynitride electrolyte


Alvotech settles with AbbVie to secure US rights to Humira biosimilar
Biotech | March 09, 2022

Alvotech settles with AbbVie to secure US rights to Humira biosimilar

Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023


Philips mobile cardiac outpatient telemetry detects Atrial Fibrillation early
Medical Device | March 09, 2022

Philips mobile cardiac outpatient telemetry detects Atrial Fibrillation early

As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone


Indian Pharma Market growth flat in Feb 2022
News | March 09, 2022

Indian Pharma Market growth flat in Feb 2022

Price was the key driver for the period


AstraZeneca partners with Indian Society of Nephrology to promote kidney health
Public Health | March 09, 2022

AstraZeneca partners with Indian Society of Nephrology to promote kidney health

Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health